Before and After Convalescent Plasma Therapy for Covid-19 Patients at Jemursari Islamic Hospital
-
Published:2021-12-31
Issue:2
Volume:4
Page:107-111
-
ISSN:2580-7730
-
Container-title:Medicra (Journal of Medical Laboratory Science/Technology)
-
language:
-
Short-container-title:medicra
Author:
Rachmayanti Notrisia,Bermawi Bastiana,Nugraha Gilang,Ballihgoo Hamiduumajid Ballihg
Abstract
The World Health Organization declared Covid-19 as a Public Health Emergency of International Concern in January 2020. Treatment options for Covid-19 are still limited, so the health system is looking for a strategy to deal with Covid-19 by using convalescent plasma therapy. This study aims to analyze differences in plasma D-Dimer levels before and after convalescent plasma therapy. This study is an analytic observational study with a retrospective design approach. D-Dimer data were taken from medical records of Covid -19 patients who received convalescent plasma therapy and were treated at Jemursari Islamic Hospital from January to March 2021. A total of 117 patients received convalescent plasma therapy and D-Dimer examinations were performed. Plasma D-Dimer levels were analyzed using statistical tests and the result was p = 0.227. The results of p > 0.05 can be concluded that there is no difference between plasma D-Dimer levels before and after convalescent plasma therapy in Covid-19 patients treated at Jemursari Islamic Hospital.
Publisher
Universitas Muhammadiyah Sidoarjo
Reference11 articles.
1. Agarwal, A., Mukherjee, A., Kumar, G., Chatterjee, P., Bhatnagar, T., & Malhotra, P. (2020). Convalescent Plasma In The Management Of Moderate Covid-19 In Adults In India: Open Label Phase II Multicentre Randomised Controlled Trial (PLACID Trial). British Medical Journal, 371. doi:10.1136/bmj.m3939. 2. Huang, S., Shen, C., Xia, C., Huang, X., Fu, Y., & Tian, L. (2020). A Retrospective Study On The Effects Of Convalescent Plasma Therapy In 24 Patients Diagnosed With Covid-19 Pneumonia In February And March 2020 At 2 Centers In Wuhan, China. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 26, e928755-1. doi: 10.12659/MSM.928755 3. Hunt, B. J., & Levi, M. (2020). Re The Source Of Elevated Plasma D‐dimer Levels In COVID‐19 Infection. British Journal of Haematology. Doi: 4. 1111/bjh.16907 5. Joyner, M. J., Carter, R. E., Senefeld, J. W., Klassen, S. A., Mills, J. R., Johnson, P. W., Theel, E. S., Wiggins, C. C., Bruno, K. A., Klompas, A. M., Lesser, E. R., Kunze, K. L., Sexton, M. A., Diaz Soto, J. C., Baker, S. E., Shepherd, J., van Helmond, N., Verdun, N. C., Marks, P., van Buskirk, C. M., … Casadevall, A. (2021). Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. The New England journal of medicine, 384(11), 1015–1027. doi: 10.1056/NEJMoa2031893
|
|